Jonathan Trujillo
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- interferon and immune responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
-
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 3
- Co-authors
- Jason J. Luke (2 shared papers)Riyue Bao (1 shared paper)Randy F. Sweis (3 shared papers)Thomas F. Gajewski (9 shared papers)Stanley Perlman (4 shared papers)Yuanyuan Zha (7 shared papers)Zuly E. Parra (3 shared papers)Robert D. Miller (3 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Immunology Research (2 papers)Journal of Virology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Jonathan Trujillo
18 papers receiving 695 citations
Peers
Comparison fields: 5 of 74
- Immunology 320
- Oncology 301
- Infectious Diseases 73
- Cancer Research 54
- Molecular Biology 164
Countries citing papers authored by Jonathan Trujillo
This map shows the geographic impact of Jonathan Trujillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Trujillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Trujillo more than expected).
Fields of papers citing papers by Jonathan Trujillo
This network shows the impact of papers produced by Jonathan Trujillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Trujillo. The network helps show where Jonathan Trujillo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Trujillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 291 | |
| 2 | 2019 | 110 | |
| 3 | 2008 | 61 | |
| 4 | 2014 | 46 | |
| 5 | 2022 | 32 | |
| 6 | 2010 | 31 | |
| 7 | 2012 | 31 | |
| 8 | 2009 | 28 | |
| 9 | 2021 | 17 | |
| 10 | 2022 | 14 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2014 | 8 | |
| 14 | 2024 | 6 | |
| 15 | 2025 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2009 | 1 | |
| 19 | 2025 | 0 | |
| 20 | Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection | 2020 | 0 |
About Jonathan Trujillo
Jonathan Trujillo is a scholar working on Oncology, Immunology, Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 700 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Ferroptosis and cancer prognosis (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Immunology (320 citations), Oncology (301 citations), Infectious Diseases (73 citations), Cancer Research (54 citations) and Molecular Biology (164 citations). Jonathan Trujillo has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Jason J. Luke, Riyue Bao, Randy F. Sweis, Thomas F. Gajewski, Stanley Perlman, Yuanyuan Zha, Zuly E. Parra, Robert D. Miller, Jeremy P. Segal and Stefani Spranger. Their work appears in journals such as Clinical Cancer Research, Cancer Immunology Research, Journal of Virology, Journal for ImmunoTherapy of Cancer and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.